Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Tobias Müller, Susanne Fay, Rodolfo Paula Vieira, Harry Karmouty-Quintana, Sanja Cicko, Korcan Ayata, Gernot Zissel, Torsten Goldmann, Giuseppe Lungarella, Davide Ferrari, Francesco Di Virgilio, Bernard Robaye, Jean-Marie Boeynaems, Michael R. Blackburn, Marco Idzko
Published Mar 21, 2017 · Vol. 8, No. 22 · pp. 35962-35972
Fabian Dominik Mairinger, Claudia Vollbrecht, Elena Flom, Daniel Christian Christoph, Kurt-Werner Schmid, Jens Kollmeier, Helmut Hans Popper, Thomas Mairinger, Robert Fred Henry Walter
Published Mar 21, 2017 · Vol. 8, No. 23 · pp. 37502-37510
Lars F. Petersen, Alexander C. Klimowicz, Shannon Otsuka, Anifat A. Elegbede, Stephanie K. Petrillo, Tyler Williamson, Chris T. Williamson, Mie Konno, Susan P. Lees-Miller, Desiree Hao, Don Morris, Anthony M. Magliocco, D. Gwyn Bebb
Published Mar 15, 2017 · Vol. 8, No. 24 · pp. 38326-38336